Pennsylvania 2025_0 Regular Session Status: In Committee 16 D cosponsors

HB 2819 — An Act amending the act of May 17, 1921 (P.L.682, No.284), known as The Insurance Company Law of 1921, in casualty insurance, further providing for coverage for biomarker testing.

Last action — Referred to INSURANCE, Oct. 2, 2026

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill is in committee in the House. Introduced October 02, 2026. It must pass committee before a floor vote.

Next likely step: a committee vote, then a floor vote in the House.

In plain language

The bill requires insurance coverage for biomarker testing for preeclampsia.

This legislation mandates that health insurers in Pennsylvania cover biomarker testing for preeclampsia, both for screening and diagnosis. Coverage cannot involve any out-of-pocket costs for the insured.

What this means for you
  • Healthcare: This means healthcare providers must ensure patients have access to necessary biomarker testing for preeclampsia.

Summary

Insurance Coverage of Preeclampsia Testing

Bill Text

How this bill changes current law

1 change Share ↗

AI-generated reading aid from the bill's amendatory text — verify against the official bill.

The bill mandates coverage for biomarker testing for preeclampsia without cost-sharing in health insurance policies in Pennsylvania.

  • Section 635.9

    An insurer that offers, issues or renews a health insurance policy in this Commonwealth shall provide coverage for biomarker testing for preeclampsia for screening of a covered person who is asymptomatic and diagnosis and management of a covered person who is symptomatic. Coverage required under this subsection may not be subject to cost-sharing.

    This adds a requirement for health insurance policies to cover biomarker testing for preeclampsia without any cost-sharing.

Action History

  1. Referred to INSURANCE, Oct. 2, 2026

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 15 co-sponsors · 237 not signed on

Sponsors (1)

Co-sponsors (15)

Not signed on (237)

237 members have not signed on to this bill.

Show all 237 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HB 2819 do?
Insurance Coverage of Preeclampsia Testing
Who sponsors HB 2819?
HB 2819 is sponsored by Liz Hanbidge (Democratic), Joe Webster (Democratic), Carol Hill-Evans (Democratic), Danielle Friel Otten (Democratic), Chris Pielli (Democratic), Emily Kinkead (Democratic), Nikki Rivera (Democratic), Benjamin V. Sanchez (Democratic), Melissa L. Shusterman (Democratic), Nancy Guenst (Democratic), Joseph C. Hohenstein (Democratic), Jeanne McNeill (Democratic), Kyle Donahue (Democratic), Dan K. Williams (Democratic), Johanny Cepeda-Freytiz (Democratic), and Darisha K. Parker (Democratic).
What is the current status of HB 2819?
This bill is in committee in the House. Introduced October 02, 2026. It must pass committee before a floor vote.
Where can I track HB 2819?
Track HB 2819 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 2819

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Stay ahead of HB 2819

Last checked for changes 21 days ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →